Supernus Pharmaceuticals (SUPN) Insider Trading & Ownership $32.29 -0.13 (-0.40%) Closing price 04:00 PM EasternExtended Trading$32.28 -0.01 (-0.03%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Supernus Pharmaceuticals (NASDAQ:SUPN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$6.10 M Get SUPN Insider Trade Alerts Want to know when executives and insiders are buying or selling Supernus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SUPN Insider Buying and Selling by Quarter Remove Ads Supernus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/21/2025Jonathan RubinSVPSell927$39.15$36,292.05 2/4/2025Padmanabh P BhattVPSell9,477$39.70$376,236.90 1/28/2025Padmanabh P BhattVPSell700$39.62$27,734.00 11/7/2024Frank MottolaSVPSell15,000$36.98$554,700.00 11/7/2024Georges GemayelDirectorSell14,213$36.62$520,480.06 11/7/2024Jack A KhattarCEOSell125,000$36.68$4,585,000.00 (Data available from 1/1/2013 forward) SUPN Insider Trading Activity - Frequently Asked Questions Who is on Supernus Pharmaceuticals's Insider Roster? The list of insiders at Supernus Pharmaceuticals includes Frank Mottola, Frederick M Hudson, Georges Gemayel, Jack A Khattar, Jonathan Rubin, Padmanabh P Bhatt, and Tami Tillotson Martin. Learn more on insiders at SUPN. What percentage of Supernus Pharmaceuticals stock is owned by insiders? 9.30% of Supernus Pharmaceuticals stock is owned by insiders. Learn more on SUPN's insider holdings. Which Supernus Pharmaceuticals insiders have been selling company stock? The following insiders have sold SUPN shares in the last 24 months: Frank Mottola ($585,924.30), Frederick M Hudson ($259,150.50), Georges Gemayel ($520,480.06), Jack A Khattar ($4,585,000.00), Jonathan Rubin ($36,292.05), Padmanabh P Bhatt ($1,631,404.11), and Tami Tillotson Martin ($644,694.65). How much insider selling is happening at Supernus Pharmaceuticals? Insiders have sold a total of 232,494 Supernus Pharmaceuticals shares in the last 24 months for a total of $8,262,945.67 sold. Supernus Pharmaceuticals Key ExecutivesMr. Jack A. Khattar (Age 63)Founder, President, CEO, Secretary & Director Compensation: $1.63M1 recent tradesMr. Timothy C. Dec (Age 65)Senior VP & CFO Compensation: $635.43kDr. Padmanabh P. Bhatt Ph.D. (Age 67)Chief Scientific Officer & Senior VP of Intellectual Property Compensation: $594.14kMr. Frank Mottola (Age 52)Senior Vice President of Quality, GMP Operations & Information Technology Compensation: $490.87k1 recent tradesDr. Jonathan Rubin M.D. (Age 63)MBA, Senior VP of Research & Development and Chief Medical Officer Compensation: $594.65kMr. Kevin T. Anderson (Age 62)Compliance Officer Dr. Todd Horich M.B.A.Ph.D., Senior Vice President of Marketing & Market AccessMr. Taylor RaifordSenior Vice President of SalesDr. Bryan A. Roecklein Ph.D.Senior Vice President of Corporate DevelopmentMs. Tami T. Martin Esq. (Age 69)R.N., Senior Vice President of Regulatory Affairs Compensation: $508.5k More Insider Trading Tools from MarketBeat Related Companies CORT Insider Selling PRGO Insider Selling PCRX Insider Selling OMER Insider Selling NKTR Insider Selling ASMB Insider Selling CPIX Insider Selling LLY Insider Selling JNJ Insider Selling ABBV Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:SUPN) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SUPN Stock Free SUPN Stock Alerts